SOUTH SAN FRANCISCO, Calif., Oct. 29, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2010 results on Thursday, November 4, 2010. A conference call and webcast hosted by OXiGENE management will begin at 4:30 p.m. EDT (1:30 p.m. PDT).
